Treatment of low-grade gliomas in children: An update

Expert Review of Neurotherapeutics

Volumn 4, Issue 6, 2004, Pages 1005-1014

  Zacharoulis, Stergios ^b   Kieran, Mark W ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Brain tumor; Chemotherapy; Low grade glioma; Pathology; Pediatric; Prognosis radiation; Surgery

Indexed keywords

ANGIOGENESIS INHIBITOR; CARBOPLATIN; DACTINOMYCIN; ETOPOSIDE; IMMUNOLOGIC AGENT; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; TIOGUANINE; VINCRISTINE;

BRAIN RADIOGRAPHY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SUSCEPTIBILITY; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; GLIOMA; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; MORBIDITY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; TOXICITY; TREATMENT OUTCOME;

BRAIN NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; DRUG THERAPY; GLIOMA; HUMANS; RADIOTHERAPY; SPECIALTIES, SURGICAL; TREATMENT OUTCOME;

EID: 8344245320     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.4.6.1005     Document Type: Review

References (99)

1. Pollack IF. Brain tumors in children. N. Engl J. Med. 331(22), 1500-1507 (1994).
2. Rekate HL, Rakfal SM. Low-grade astrocytomas of childhood. Neurol. Clin. 9(2), 423-440 (1991).
3. Fisher BJ, Leighton CC, Vujovic O, Macdonald DR, Stitt L. Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int. J. Radiat. Oncol. Biol. Phys. 51(3), 704-710 (2001).
4. Perilongo G, Garre ML, Giangaspero F. Low-grade glioma and leptomeningeal dissemination: a poorly understood phenomenon. Childs Nerv. Syst. 19(4), 197-203 (2003).
5. Stupp R, Baumert BG. Promises and controversies in the management of low-grade glioma. Ann. Oncol. 14(12), 1695-1696 (2003).
6. Rashidi M, DaSilva VR, Minagar A, Rutka JT. Nonmalignant pediatric brain tumors. Curr. Neurol. Neurosci. Rep. 3(3), 200-205 (2003).
7. Rilliet B, Vernet O. Gliomas in children: a review. Childs Nerv. Syst. 16(10-11), 735-741 (2000). Good overview of gliomas in children, including both low and high grade.
8. Kleihues P, Schauble B, zur Hausen A, Esteve J, Ohgaki H. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am. J. Pathol. 150(1), 1-13 (1997).
9. Vinchon M, Soto-Ares G, Ruchoux MM, Dhellemmes P. Cerebellar gliomas in children with NF1: pathology and surgery. Childs Nerv. Syst. 16(7), 417-420 (2000).
10. Willert JR, Daneshvar L, Sheffield VC, Cogen PH. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocyric astrocytomas. Genes Chromosomes Can. 12(3), 165-172 (1995).
11. Cuccia V, Zuccaro G, Sosa F, Monges J, Lubienieky F, Taratuto AL. Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv. Syst. 19(4), 232-243 (2003).
12. Kieran MW. Advances in pediatric neuro-oncology. Curr. Opin. Neurol. 13(6), 627-634 (2000). Discusses of technological advances in pediatric neuro-oncology.
13. Rubin JB, Kieran MW. Innovative therapies for pediatric brain tumors. Curr. Opin. Pediatr. 11(1), 39-46 (1999). Discussess the preclinical and novel approaches that are on the horizon for pediatric brain tumor patients.
14. Giangaspero F, Kaulich K, Cenacchi G et al. Lipoastrocytoma: a rare low-grade astrocytoma variant of pediatric age. Acta Neuropathol. (Berl) 103(2), 152-156 (2002).
15. Kleihues P, Cavenee WK (Eds). Pathology and Genetics of Tumours of the Nervous System, World Health Organization Classification of Tumours. IARC Press: Lyon, France (2000). Provides a simple yet informative summary of all major classes of brain tumors. While based on adult lesions, most pediatric tumors are included.
16. Yachnis AT. Neuropathology of pediatric brain tumors. Semin. Pediatr. Neurol. 4(4), 282-291 (1997).
17. Dirven CM, Koudstaal J, Mooij JJ, Molenaar WM. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuroradiological follow-up. J. Neurooncol. 37(1), 9-16 (1998).
18. Korshunov A, Golanov A Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single Institute. J. Neurooncol. 52(1), 63-72 (2001).
19. Sugita Y, Shigemori M, Okamoto K, Morimatsu M, Arakawa M, Nakayama K. Clinicopathological study of pleomorphic xanthoastrocytoma: correlation between histological features and prognosis, Pathol. Int. 50(9), 703-708 (2000).
20. Giannini C, Scheithauer BW, Burger PC et al. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 85(9), 2033-2045 (1999).
21. Orr LC, Fleitz J, McGavran L, Wyatt-Ashmead J, Handler M, Foreman NK. Cytogenetics in pediatric low-grade astrocytomas, Med. Pediatr. Oncol. 38(3), 173-177 (2002)
22. Shafqat S, Hedley-Whyte ET, Henson JW. Age-dependent rate of anaplastic transformation in low-grade astrocytoma. Neurology 52(4), 867-869 (1999).
23. Darling JL, Warr TJ. Biology and genetics of malignant brain tumours. Curr. Opin. Neurol. 11(6), 619-625 (1998).
24. Rizk T, Mottolese C, Bouffet E et al. Pediatric oligodendrogliomas. Pediatr. Neurosurg. 30(3), 166 (1999).
25. Turgut M, Tahta K, Ozcan OE, Onol B. The treatment of cerebral oligodendrogliomas with particular reference to features indicating malignancy: report of seventy-seven cases. Neurosurg. Rev. 21(2-3), 138-146 (1998).
26. Razack N, Baumgartner J, Bruner J. Pediatric oligodendrogliomas. Pediatr. Neurosurg. 28(3), 121-129 (1998).
27. Kedar A. Chemotherapy for pediatric brain tumors. Semin. Pediatr. Neurol. 4(4), 320-332 (1997).
28. Engelhard HH, Stelea A, Cochran EJ. Oligodendroglioma: pathology and molecular biology. Surg. Neurol. 58(2), 111-117 (2002).
29. Raghavan R, Balani J, Perry A et al. Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. J. Neuropathol. Exp. Neurol. 62(5), 530-537 (2003). Raises a number of issues regarding chromosomal abnormalities in adult versus pediatric tumors of the same type. With an increasing number of publications on the subclassification of oligodendroglial tumors and their treatments, understanding these differences become more important.
30. Hussein MR, Baidas S. Advances in diagnosis and management of oligodendroglioma. Expert Rev. Anticancer Ther. 2(5), 520-528 (2002).
31. Johnson JH Jr, Hariharan S, Berman J et al. Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20 years. Pediatr. Neurosurg. 27(4), 203-207 (1997).
32. Tamburrini G, Colosimo C Jr, Giangaspero F, Riccardi R, Di Rocco C. Desmoplastic infantile ganglioglioma. Childs Nerv. Syst. 19(5-6), 292-297 (2003).
33. Cabiol J, Acebes JJ, Isamat F. Dysembryoplastic neuroepithelial tumor. Crit. Revs. Neurosurg, 9(2), 116-125 (1999).
34. Zentner J, Hufnagel A, Wolf HK et al. Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 41(2), 378-386 (1997).
35. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23(5), 545-556 (1988).
36. Wolf HK, Wellmer J, Muller MB, Wiestler OD, Hufnagel A, Pietsch T. Glioneuronal malformative lesions and dysembryoplasric neuroepithelial tumors in patients with chronic pharmacoresistant epilepsies. J. Neuropathol. Exp. Neurol. 54(2), 245-254 (1995).
37. Vuori K, Kankaanranta L, Hakkinen AM et al. LGGs and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 230(3), 703-708 (2004).
38. 11C] methionine PET in the diagnosis of dysembryoplastic neuroepithelial tumor with temporal lobe epilepsy. Epilepsia 45(1), 41-45 (2004).
39. Fernandez C, Girard N, Paz Paredes A, Bouvier-Labit C, Lena G, Figarella-Branger D. The usefulness of MR imaging in the diagnosis of dysembryoplastic neuroepithelial tumor in children: a study of 14 cases. AJNR Am. J. Neuroradiol. 24(5), 829-834 (2003).
40. Stanescu Cosson R, Varlet P, Beuvon F et al. Dysembryoplastic neuroepithelial tumors: CT, MR findings and imaging follow-up: a study of 53 cases. J. Neuroradiol. 28(4), 230-240 (2001).
41. Cenacchi G, Giangaspero F. Emerging tumor entities and variants of CNS neoplasms. J. Neuropathol. Exp. Neurol. 63(3), 185-192(2004). Discusses many of the new and rare brain tumors not yet incorporated into the World Health Organization classification. If you are looking for a tumor and can not find it discussed in the standard text, this is the place to look
42. Min KW, Cashman RE, Brumback RA. Glioneurocytoma: tumor with glial and neuronal differentiation. J. Child. Neurol. 10(3), 219-226 (1995).
43. Dcsai KI, Nadkarni TD, Muzumdar DP, Goel A. Prognostic factors for cerebellar astrocytomas in children: a study of 102 cases. Pediatr. Neurosurg. 35(6), 311-317 (2001).
44. Gajjar A. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J. Clin. Oncol. 15(8), 2792-2799 (1997).
45. Fouladi M, Jenkins J, Burger P et al. Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro-oncology 3(3), 184-192 (2001).
46. Walker D. Recent advances in optic nerve glioma with a focus on the young patient Curr. Opin. Neurol. 16(6), 657-664 (2003). Good review of optic gliomas, one of the most common low-grade gliomas (LGGs) in pediatrics.
47. Daglioglu E, Cataltepe O, Akalan N. Tectal gliomas in children: the implications for natural history and management strategy. Pediatr. Neurosurg. 38(5), 223-231 (2003).
48. Sun B, Wang CC, Wang J. MRI characteristics of midbrain tumours. Neuroradiology 41(3), 158-162 (1999).
49. Young Poussaint T. Cervicomedullary astrocytomas of childhood: clinical and imaging follow-up. Pediatr. Radiol. 29(9), 662-668 (1999).
50. Freeman CR, Farmer JP. Pediatric brain stem gliomas: a review. Int. J. Radiat. Oncol. Biol. Phys. 40(2), 265-271 (1998).
51. Warren KE. Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. J. Clin. Oncol. 18(5), 1020-1026 (2000).
52. Lazareff JA, Bockhorst KH, Curran J, Olmstead C, Alger JR. Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging. Neurosurgery 43(4), 809-817 (1998).
53. Korf BR. Diagnosis and management of neurofibromatosis Type 1. Curr. Neurol. Neurosci. Rep. 1(2), 162-167 (2001). Neurofibromatosis Type 1 is one of the most common genetic diseases in North America and 15% of these individuals will have an optic glioma. Treatment strategies for neurofibromatosis Type 1 patients differ significantly from other patients and this article discusses many of the unique factors in this patient population.
54. Guillamo JS. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 126(Pt 1), 152-160 (2003).
55. Singhal S, Birch JM, Kerr B, Lashford L, Evans DG. Neurofibromatosis Type 1 and sporadic optic gliomas. Arch. Dis. Child. 87 (1), 65-70 (2002).
56. Tow SL, Chandela S, Miller NR, Avellino AM. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr. Neurol. 28(4), 262-270 (2003).
57. Wellons JC III. Long-term control of hydrocephalus via endoscopic third ventriculostomy in children with tectal plate gliomas. Neurosurgery 51(1), 63-68 (2002). The increasing expertise with this technique and decreased acute and long-term morbidity make it an important component of neurosurgical care. Centers unable to perform this technique should consider referral to a larger program where it is available.
58. Pollack IF, Pang D, Albright AL. The long-term outcome in children with late-onset aqueductal stenosis resulting from benign intrinsic tectal tumors. J. Neurosurg. 80(4), 681-688 (1994).
59. Bowers DC. Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr. Neurosurg. 32(1), 24-29 (2000).
60. Packer RJ. Diagnosis and treatment of pediatric brain tumors. Curr. Opin. Neurol. 7(6), 484-491 (1994).
61. Pollack IF. The role of surgery in pediatric gliomas. J. Neurooncol. 42(3), 271-288 (1999). Excellent overview of surgical options in pediatric patients with CNS tumors.
62. Grill J, Laithier V, Rodriguez D, Raquin MA, Pierre-Kahn A, Kalifa C. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur. J. Pediatr. 159(9), 692-696 (2000).
63. Hoffman HJ. Brainstem gliomas. Clin. Neurosurg. 44, 549-558 (1997).
64. Meyer EA, Kieran MW. Psychological adjustment of surgery-only pediatric neuro-oncology patients: a retrospective analysis. Psychooncology 11(1), 74-79 (2002). Limited study on surgery-only patients with LGG which demonstrates that even those thought to be the lucky ones demonstrated effects from having a tumor and surgery.
65. Lagares A, Gomez PA, Lobato RD, Ricoy JR, Ramos A, de la Lama A. Ganglioglioma of the brainstem: report of three cases and review of the literature. Surg. Neurol. 56 (5), 315-322 (2001).
66. Disabato JA, Handler MH, Strain JD, Fleitz JM, Foreman NK. Successful use of intracavitary bleomycin for low-grade astrocytoma tumor cyst. Pediatr. Neurosurg. 31 (5), 246-250 (1999). Cystic lesions, while considered nonmalignant, continue to cause a great deal of morbidity. This paper on the use of bleomycin offers a novel therapy for some of these patients.
67. Bowers DC. Second surgery for recurrent pilocytic astrocytoma in children. Pediatr. Neurosurg. 34(5), 229-234 (2001).
68. Saran FH, Baumert BG, Khoo VS et al Stereotactically guided conformal radiotherapy for progressive LGGs of childhood. Int. J. Radiat. Oncol. Biol. Phys. 53 (1), 43-51 (2002).
69. Plathow C, Schulz-Ertner D, Thilman C et al. Fractionated stereotactic radiotherapy in low-grade astrocytomas: long-term outcome and prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 57 (4), 996-1003 (2003).
70. Schulz-Ertner D, Debus J, Lohr F, Frank C, Hoss A, Wannenmacher M. Fractionated stereotactic conformal radiation therapy of brain stem gliomas: outcome and prognostic factors. Radiother. Oncol. 57 (2), 215-223 (2000).
71. Freeman CR, Bourgouin PM, Sanford RA, Cohen ME, Friedman HS, Kun LE. Long-term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. Cancer 77 (3), 555-562 (1996).
72. Merchant TE, Zhu Y, Thompson SJ, Sontag MR, Heideman RL, Kun LE. Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma. Int. J. Radiat. Oncol Biol. Phys. 52 (2), 325-332 (2002). Demonstrates the activity of highly conformal radiation therapy in pediatric patients with LGGs.
73. Marcus KJ. Stereotactic radiotherapy for localized LGGs in children: final results of a prospective trial. Int. J. Radiat. Oncol. Biol. Phys. 57 (Suppl. 2), S196 (2003).
74. Packer RJ. Brain tumors in children. Arch. Neurol. 56 (4), 421-425 (1999).
75. Jenkin D, Danjoux C, Greenberg M. Subsequent quality of life for children irradiated for a brain tumor before age four years. Med. Pediatr. Oncol. 31(6), 506-511 (1998).
76. Fuchs I, Kreil W, Sutter B, Papaethymiou G, Pendl G. Gamma knife radiosurgery of brainstem gliomas. Acta. Neurochir. 84 (Suppl.), 85-90 (2002).
77. Hadjipanayis CG, Niranjan A, Tyler-Kabara E, Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for well-circumscribed fibrillary grade II astrocytomas: an initial experience. Stereotact. Funct. Neurosurg. 79(1), 13-24 (2002).
78. Hadjipanayis CG. Stereotactic radiosurgery for pilocytic astrocytomas when multimodal therapy is necessary. J. Neurosurg. 97 (1), 56-64 (2002).
79. Fuss M, Hug EB, Schaefer RA et al. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int. J. Radiat. Oncol. Biol. Phys. 45 (5), 1117-1126 (1999).
80. Rosenstock JG, Packer RJ, Bilaniuk L, Bruce DA, Radcliffe JL, Savino P. Chiasmatic optic glioma treated with chemotherapy. A preliminary report J. Neurosurg. 63 (6), 862-866 (1985).
81. Lefkowitz IB. Results of the treatment of children with recurrent gliomas with lomustine and vincristine. Cancer 61 (5), 896-902 (1988).
82. Chamberlain MC, Grafe MR. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. J. Clin. Oncol. 13 (8), 2072-2076 (1995).
83. Kobrinsky NL. Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881. J. Neurooncol. 45 (1), 47-54 (1999).
84. Packer RJ, Ater J, Allen J et al. Carboplatin and vincristinc chemotherapy for children with newly diagnosed progressive LGGs. J. Neurosurg. 86 (5), 747-754 (1997). This report (and earlier publications of the same study) has become the standard of care for patients around the world with LGGs.
85. Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA. Treatment of pediatric LGGs with a nitrosourea-based multiagent chemotherapy regimen. J. Neurooncol. 32 (3), 235-241 (1997). Has become the other standard therapy for most LGGs.
86. Heath JA, Turner CD, Poussaint TY, Scott RM, Goumnerova L, Kieran MW. Chemotherapy for progressive LGGs in children older than ten years: the Dana-Farber experience. Pediatr. Hematol. Oncol. 20 (7), 497-504 (2003).
87. Gururangan S. Phase II study of carboplatin in children with progressive low-grade glioma. J. Clin. Oncol. 20 (13), 2951-2958 (2002).
88. McLaughlin ME, Robson CD, Kieran MW, Jacks T, Pomeroy SL, Cameron S. Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): a case report and laboratory investigation. J. Pediatr. Hematol. Oncol. 25 (8), 644-648 (2003).
89. Quinn JA. Phase II trial of temozolomide in patients with progressive low-grade glioma. J. Clin. Oncol. 21 (4), 646-651 (2003).
90. Kuo DJ, Weiner HL, Wisoff J, Miller DC, Knopp EA, Finlay JL. Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas. J. Pediatr. Hematol. Oncol. 25 (5), 372-378 (2003). The addition of temozolomide for recurrent LGG is under study and is being considered for addition to the vincristine/carboplatin and TPCV therapies discussed above.
91. Gajjar A Response of pediatric low grade gliomas to chemotherapy. Pediatr. Neurosurg. 19 (3), 113-120 (1993).
92. Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M. LGGs of the cerebral hemispheres in children: an analysis of 71 cases. J. Neurosurg. 82(4), 536-547 (1995).
93. Reardon DA. Bithalamic involvement predicts poor outcome among children with thalamic glial tumors. Pediatr. Neurosurg. 29 (1), 29-35 (1998).
94. Anderson NE. Late complications in childhood central nervous system tumour survivors. Curr. Opin. Neurol. 16 (6), 677-683 (2003).
95. Barr RD, Simpson T, Whitton A, Rush B, Furlong W, Feeny DH. Health-related quality of life in survivors of tumours of the central nervous system in childhood-a preference-based approach to measurement in a cross-sectional study. Eur. J. Cancer 35 (2), 248-255 (1999).
96. Oeffinger KC. Healthcare of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann. Fam. Med. 2 (1), 61-70 (2004). Large review of the SEER database demonstrating the long-term morbidities that survivors of brain tumors face. This article again focuses on the need to balance efficacy with long-term impact.
97. Carpentieri SC, Waber DP, Pomeroy SL et al. Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery 52(6), 1348-1356 (2003).
98. Epstein F, Constantini S. Practical decisions in the treatment of pediatric brain stem tumors. Pediatr. Neurosurg. 24 (1), 24-34 (1996).
99. Robertson PL, Allen JC, Abbott IR, Miller DC, Fidel J, Epstein FJ, Cervicomedullary tumors in children: a distinct subset of brainstem gliomas. Neurology 44 (10), 1798-1803 (1994).